Literature DB >> 10218953

Salsola tuberculatiformis Botschantzev and an aziridine precursor analog mediate the in vivo increase in free corticosterone and decrease in corticosteroid-binding globulin in female Wistar rats.

A Louw1, P Swart.   

Abstract

Salsola tuberculatiformis Botschantzev causes prolonged gestation in sheep and contraception in rats. An active fraction isolated from the shrub, containing a highly labile hydoxyphenyl aziridine or precursor, and a more stable analog, compound A, inhibits sheep adrenal cytochrome P450c11. In addition, compound A has been shown to bind to and be stabilized by corticosteroid-binding globulin (CBG). Binding may result in concomitant displacement of endogenous steroids, which could contribute to the biological effects of these compounds. The present study was undertaken to establish which mechanism would predominate in female rats. Compound A significantly (P < 0.01) displaced glucocorticoids, but not progesterone, from rat CBG in vitro, whereas in vivo the percentage of free plasma corticosterone in both S. tuberculatiformis (P < 0.05)- and compound A (P < 0.01)-treated rats was also significantly higher due to displacement from CBG. In addition, both ACTH and CBG concentrations were significantly (P < 0.05) lower than control values. The levels of the gonadotropins were also reduced during treatment, but only LH values significantly (P < 0.05) so. These results suggest that binding of the test substances to CBG in female rat plasma and concomitant displacement of endogenous corticosterone could be part of the contraceptive mechanism of S. tuberculatiformis and the aziridine precursor, compound A.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10218953     DOI: 10.1210/endo.140.5.6680

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Nongenomic actions of adrenal steroids in the central nervous system.

Authors:  N K Evanson; J P Herman; R R Sakai; E G Krause
Journal:  J Neuroendocrinol       Date:  2010-03-27       Impact factor: 3.627

2.  A fully dissociated compound of plant origin for inflammatory gene repression.

Authors:  Karolien De Bosscher; Wim Vanden Berghe; Ilse M E Beck; Wim Van Molle; Nathalie Hennuyer; Janet Hapgood; Claude Libert; Bart Staels; Ann Louw; Guy Haegeman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

3.  A glucocorticoid-receptor agonist ameliorates bleomycin-induced alveolar simplification in newborn rats.

Authors:  Shoichi Ishikawa; Tohru Ogihara; Shigeo Yamaoka; Jun Shinohara; Shigeru Kawabata; Yoshinobu Hirose; Daisuke Nishioka; Akira Ashida
Journal:  Pediatr Res       Date:  2022-09-06       Impact factor: 3.953

4.  Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.

Authors:  Simone Wüst; Denise Tischner; Michael John; Jan P Tuckermann; Christiane Menzfeld; Uwe-Karsten Hanisch; Jens van den Brandt; Fred Lühder; Holger M Reichardt
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

5.  Compound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor Transrepression.

Authors:  Yichun Zheng; Hitoshi Ishiguro; Hiroki Ide; Satoshi Inoue; Eiji Kashiwagi; Takashi Kawahara; Mehrsa Jalalizadeh; Leonardo O Reis; Hiroshi Miyamoto
Journal:  Mol Endocrinol       Date:  2015-08-31

6.  Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.

Authors:  Steven Robertson; Fatima Allie-Reid; Wim Vanden Berghe; Koch Visser; Anke Binder; Donita Africander; Michael Vismer; Karolien De Bosscher; Janet Hapgood; Guy Haegeman; Ann Louw
Journal:  J Biol Chem       Date:  2009-12-26       Impact factor: 5.157

7.  Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects.

Authors:  Clemens Honeder; Elisabeth Engleder; Hanna Schöpper; Markus Krause; Lukas David Landegger; Roberto Plasenzotti; Franz Gabor; Wolfgang Gstoettner; Christoph Arnoldner
Journal:  Laryngoscope       Date:  2014-11-10       Impact factor: 3.325

Review 8.  Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.

Authors:  Ekaterina Lesovaya; Alexander Yemelyanov; Amanda C Swart; Pieter Swart; Guy Haegeman; Irina Budunova
Journal:  Oncotarget       Date:  2015-10-13

Review 9.  The Role of Glucocorticoid Receptor Signaling in Bladder Cancer Progression.

Authors:  Hiroki Ide; Satoshi Inoue; Hiroshi Miyamoto
Journal:  Cancers (Basel)       Date:  2018-12-04       Impact factor: 6.639

10.  Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells.

Authors:  Mutita Junking; Thidarath Rattanaburee; Aussara Panya; Irina Budunova; Guy Haegeman; Pa-Thai Yenchitsomanus
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.